Literature DB >> 24497011

Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals.

Benjamin P Burke1, Gonçalo S Clemente, Stephen J Archibald.   

Abstract

Gallium-68 has the potential to become the technetium-99m of positron emission tomography with ideal decay characteristics and a long-lived parent isotope for generator production. The work in the area of (68) Ga is focused on two key areas: (1) synthesis of a library of bifunctional chelators, which can be quickly radiolabelled to form kinetically inert complexes under mild conditions compatible with biomolecules and (2) development of radiosynthetic methodologies for clinical use and to facilitate radiolabelling of a wide range of chelators under mild conditions. Recent advances in these areas, with particular focus on the past 3 years, are covered herein.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  chelator; gallium-68; macrocycle; positron emission tomography; radiopharmaceutical

Mesh:

Substances:

Year:  2014        PMID: 24497011     DOI: 10.1002/jlcr.3146

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  8 in total

Review 1.  Positron emission tomography imaging using radiolabeled inorganic nanomaterials.

Authors:  Xiaolian Sun; Weibo Cai; Xiaoyuan Chen
Journal:  Acc Chem Res       Date:  2015-01-30       Impact factor: 22.384

2.  Incorporation of gallium-68 into the crystal structure of Prussian blue to form K(68)GaxFe1-x[Fe(CN)6] nanoparticles: toward a novel bimodal PET/MRI imaging agent.

Authors:  Murthi S Kandanapitiye; Matthew D Gott; Andrew Sharits; Silvia S Jurisson; Patrick M Woodward; Songping D Huang
Journal:  Dalton Trans       Date:  2016-05-31       Impact factor: 4.390

Review 3.  A nuclear chocolate box: the periodic table of nuclear medicine.

Authors:  Philip J Blower
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

Review 4.  Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.

Authors:  Irina Velikyan
Journal:  Contrast Media Mol Imaging       Date:  2018-01-04       Impact factor: 3.161

5.  Cyclic 68Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2.

Authors:  Matthew F L Parker; Joseph Blecha; Oren Rosenberg; Michael Ohliger; Robert R Flavell; David M Wilson
Journal:  J Nucl Med       Date:  2021-02-26       Impact factor: 11.082

Review 6.  Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?

Authors:  Nicolas Lepareur
Journal:  Front Med (Lausanne)       Date:  2022-02-10

7.  Comparative evaluation of 68Ga-labelled TATEs: the impact of chelators on imaging.

Authors:  Yuxiao Xia; Chengrun Zeng; Yanhong Zhao; Xinyi Zhang; Zibo Li; Yue Chen
Journal:  EJNMMI Res       Date:  2020-04-15       Impact factor: 3.138

Review 8.  Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.

Authors:  Stephane Demine; Michael L Schulte; Paul R Territo; Decio L Eizirik
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.